Evercore ISI raised the firm’s price target on Moderna (MRNA) to $50 from $35 and keeps an In Line rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Why Is SPDR S&P 500 ETF Trust (SPY) Up Today, 5/1/2026?
- Moderna Earnings Call: Revenue Rebound, Legal Overhang
- Moderna price target raised to $49 from $43 at Goldman Sachs
- Moderna price target raised to $33 from $30 at Morgan Stanley
- Midday Fly By: Apple reports Q2 beat, oil majors post mixed results